Oxidized low-density lipoprotein (oxidized LDL) and the risk of preeclampsia

Physiological Research

Volumn 55, Issue 5, 2006, Pages 491-500

  Qiu, Chunfang ^a   Phung, T T T ^b   Vadachkoria, S ^a   Muy Rivera, M ^a   Sanchez, S E ^c   Williams, M A ^a,b  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MINISTERIO DE SALUD   (Peru)

Author keywords

Lipids; Oxidized LDL; Preeclampsia; Risk factors; Vitamin C

Indexed keywords

ASCORBIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FAMILY HISTORY; FEMALE; HUMAN; IMMOBILIZATION; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NULLIPARA; OXIDATIVE STRESS; PATHOGENESIS; PREECLAMPSIA; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; ASCORBIC ACID; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPOPROTEINS, LDL; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; TRIGLYCERIDES;

EID: 33750276690     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS: Hypertension in pregnancy. ACOG Technical Bull 219: 1-8, 1996.
2. BERLINER JA, NAVAB M, FOGELMAN AM, FRANK JS, DEMER LL, EDWARDS PA, WATSON AD, LUSIS AJ: Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496, 1995.
3. BOWEN RS, MOODLEY J, DUTTON MF, FICKL H: Antibodies to oxidised low-density lipoproteins and cardiolipin in pre-eclampsia and eclampsia. J Obstet Gynaecol 22: 123-126, 2002.
4. BRANCH DW, MITCHELL MD, MILLER E, PALINSKI W, WITZTUM JL: Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 343: 645-646, 1994.
5. CHISOLM GM 3RD, HAZEN SL, FOX PL, CATHCART MK: The oxidation of lipoproteins by monocytesmacrophages. Biochemical and biological mechanisms. J Biol Chem 274: 25959-25962, 1999.
6. ENQUOBAHRIE DA, WILLIAMS MA, BUTLER CL, FREDERCIK IO, MILLER RS, LUTHY DA: Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 17: 574-581, 2004.
7. FIALOVÁ L, MIKULÍKOVÁ L, MALBOHAN I, BENEŠOVÁ O, ŠTÍPEK S, ZIMA T, ZWINGER A: Antibodies against oxidized low density lipoproteins in pregnant women. Physiol Res 51: 355-361, 2002.
8. GALLE J, OCHSLEN M, SCHOLLMEYER P, WANNER C: Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Hypertension 23: 556-564, 1994.
9. HALLIWELL B, GUTTERIDGE JMC: The antioxidants of human extracellular fluids. Arch. Biochem Biophys 280: 1-8, 1990.
10. HOLVOET P, VANHAECKE J, JANSSENS S, VAN DE WERF F, COLLEN D: Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98: 1487-1494, 1998.
11. HULTHE J, FAGERBERG B: Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol. 22: 1162-1167, 2002.
12. KAAJA R, TIKKANEN MJ, VINNIKKA L, YLIKORKALA O: Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 85: 353-356, 1995.
13. KRAUSS RM: Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype. In: Genetic Variation and Dietary Response: World Review of Nutrition and Dietetics. SIMOPOULOS AP, NESTEL PJ, (eds). Karger, Basel, Vol. 80, 1997, pp 2-43.
14. KURKI T, AILUS K, PALOSUO T, YLIKORKALA O: Oxidized low-density lipoprotein, cardiolipin, and phosphatidyl serine fail to predict the risk of preeclampsia. Hypertens Pregnancy 15: 251-256, 1996.
15. LEE W, ROBERTS SM, LABBE RF: Ascorbic acid determination with an automated enzymatic procedure. Clin Chem 43: 154-157, 1997.
16. MUY-RIVERA M, NING Y, FREDERIC IO, VADCHKORIA S, LUTHY DA, WILLIAMS MA: Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk. Physiol Res 54: 167-174, 2005.
17. NATIONAL HIGH BLOOD PRESSURE EDUCATION PROGRAM WORKING GROUP ON HIGH BLOOD PRESSURE IN PREGNANCY: Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. AJOG 183: S1-S22, 2000.
18. OKATANI Y, WAKATSUKI A, WATANABE K, IKENOUE N, FUKAYA T: Melatonin inhibits vasospastic action of oxidized low-density lipoprotein in human umbilical arteries. J Pineal Res 29: 74-80, 2000.
19. PATTERSON RE, KRISTAL AR, TINKER LF, CARTER RA, BOLTON MP, AGURS-COLLINS T: Measurement characteristics of the women's health initiative food frequency questionnaire. Am J Epidemiol 9: 178-187, 1999.
20. QIU C, LUTHY DA, ZHANG C, SORENSEN TK, LEISERING WM, FREDERICK IO, WILLIAMS MA: A study of maternal serum C-reactive protein (CRP) concentrations and risk of preeclampsia. Am J Hypertens 17: 154-160, 2004.
21. RAIJMAKERS MT, VAN TITS BJ, HAK-LEMMERS HL, ROES EM, STEEGERS EA, PETERS WH: Low plasma levels of oxidized low density lipoprotein in preeclampsia. Acta Obstet Gynecol Scand 83: 1173-1177, 2004.
22. ROBERTSON WB, KHONG TY, BROSENS I, WOLF FD, SHEPPARD BL, BONNER J: The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 155: 401-412, 1986.
23. ROTHMAN KJ, GREENLAND S: Modern Epidemiology. Lippincott-Raven Publishers, Philadelphia, PA, 1998.
24. SIGURDARDOTTIR V, FAGERBERG B, HULTHE J: Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 252: 440-447, 2002.
25. SIMON BC, CUNNINGHAM LD, COHEN RA: Oxidized low-density lipoproteins cause contraction and inihibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 86: 75-79, 1990.
26. SORENSEN TK, WILLIAMS MA, LEE IM, DASHOW EE, THOMPSON ML, LUTHY DA: Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension 41: 1273-1280, 2003.
27. STEINBERG D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272: 20963-20966, 1997a.
28. STEINBERG D: Oxidative modification of LDL and atherogenesis. Circulation 95: 1062-1071, 1997b.
29. UOTILA J, SOLAKIVI T, JAAKKOLA O, TUIMALA R, LEHTIMAKI T: Antibodies against copper-oxidised and mondialdehyde-modified low-density lipoproteins in preeclamptic pregnancies. Br J Obstet Gynaecol 105: 1113-1117, 1998.
30. WALKER JJ: Pre-eclampsia. Lancet 356: 1260-1265, 2000.
31. WALSH SW: Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Sem Reprod Endocrinol 16: 93-104, 1998.
32. WANG J, ZHEN E, GUO Z, LU Y: Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: Protective effect of antioxidants. Free Radic Biol Med 7: 243-249, 1989.
33. WILLIAMS MA, FARRAND A, MITTENDORF R, SORENSEN TK, ZINGHEIM RW, O'REILLY GC, KING IB, ZEBELMAN AM, LUTHY DA: Maternal second-trimester serum tumor necrosis factor-α soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 149: 323-329, 1999.
34. WINKLER K, WSTZKA B, HOFFMANN MM, FRIEDRICH I, KINNER M, BAUMSTARK MW, ZAHRADNIK HP, WIELAND H, MARZ W: Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia. J Clin Endocrinol Metab 88: 1162-1166, 2003.
35. WITZTUM JL, HORKKO S: The role of oxidized LDL in atherogenesis: immunological response and antiphospholipid antibodies. Ann N Y Acad Sci 811: 88-96, 1997.
36. YLA-HERTTUALA S: Is oxidized low-density lipoprotein present in vivo? Curr Opin Lipidol 9: 337-344, 1998.
37. ZHANG C, WILLIAMS MA, KING IB, DASHOW EE, SORENSEN TK, FREDERCIK IO, THOMPSON ML, LUTHY DA: Vitamin C and the risk of preeclampsia - results from dietary questionnaire and plasma assay. Epidemiology 13: 409-416, 2002.